Fluge & Mella's pre-trial study highlights life-changing potential of rituximab
Sasha gives the background and Simon gives the interpretation of the latest study from Haukeland, published today...
Discuss the article on the Forums.

(US) Open Data - public views sought

Discussion in 'Other Health News and Research' started by MeSci, Feb 7, 2014.

  1. MeSci

    MeSci ME/CFS since 1995; activity level 6

    Messages:
    5,843
    Likes:
    7,677
    Cornwall, UK
    I couldn't find a thread on this, which was in NEJM 22nd January.

     
  2. alex3619

    alex3619 Senior Member

    Messages:
    9,151
    Likes:
    17,769
    Logan, Queensland, Australia
    If medical research is to be improved then open data is necessary. The debate is really about how to do this. I think that researchers should indeed have exclusive right to data for a period of time, but the debate is really on how long that should be. Immediate release might be too soon, several years later is definitely too late.

    If the PACE trial had public data release after one year, then we would now have possibly disproven their findings. So I wonder how much that kind of research will agree with open data? I also wonder what they mean by open data. Its not a drug trial, they might argue that for some reason they should be exempt. They might also have half-way open data, in which the public has no access but only certain groups.
     
    Valentijn likes this.

See more popular forum discussions.

Share This Page